Kasteng F, Erlanson M, Hagberg H, Kimby E, Relander T, Lundkvist J. Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden. AO [Internet]. 2008 Jan. 1 [cited 2025 Feb. 21];47(6):1029-36. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25895